$8.03
-0.16[-1.95%]
At close: Apr 12
$8.03
0[0.00%]
PreMarket: 9:30AM EDT
Profound Medical
(NASDAQ:PROF)Profound Medical Stock (NASDAQ:PROF), Analyst Ratings, Price Targets, Predictions
Profound Medical Corp has a consensus price target of $12.11, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from Alliance Global Partners, Stifel, and Alliance Global Partners on March 11, 2024, March 8, 2024, and January 4, 2024. With an average price target of $10.85 between Alliance Global Partners, Stifel, and Alliance Global Partners, there's an implied 35.12% upside for Profound Medical Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Alliance Global Partners
Stifel
Raymond James
TD Cowen
Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Profound Medical
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/11/2024 | PROF | Buy Now | Profound Medical | $8.03 | 34.5% | Alliance Global Partners | Ben Haynor | $12.75 → $10.8 | Maintains | Buy | Get Alert |
| 03/08/2024 | PROF | Buy Now | Profound Medical | $8.03 | 12.08% | Stifel | Rick Wise | $11 → $9 | Maintains | Hold | Get Alert |
| 01/04/2024 | PROF | Buy Now | Profound Medical | $8.03 | 58.78% | Alliance Global Partners | Ben Haynor | $14.25 → $12.75 | Maintains | Buy | Get Alert |
| 11/28/2023 | PROF | Buy Now | Profound Medical | $8.03 | 36.99% | Stifel | Rick Wise | → $11 | Initiates | → Hold | Get Alert |
| 08/04/2023 | PROF | Buy Now | Profound Medical | $8.03 | — | Raymond James | Rahul Sarugaser | — | Downgrade | Strong Buy → Outperform | Get Alert |
| 05/11/2023 | PROF | Buy Now | Profound Medical | $8.03 | 124.16% | TD Cowen | Joshua Jennings | $14 → $18 | Maintains | Outperform | Get Alert |
| 05/11/2023 | PROF | Buy Now | Profound Medical | $8.03 | 96.14% | Alliance Global Partners | Ben Haynor | $13.15 → $15.75 | Maintains | Buy | Get Alert |
| 03/21/2023 | PROF | Buy Now | Profound Medical | $8.03 | 24.53% | Jefferies | Michael Sarcone | $5.5 → $10 | Downgrade | Buy → Equal-Weight | Get Alert |
| 11/04/2022 | PROF | Buy Now | Profound Medical | $8.03 | — | Raymond James | Rahul Sarugaser | — | Upgrade | Outperform → Strong Buy | Get Alert |
| 03/07/2022 | PROF | Buy Now | Profound Medical | $8.03 | 74.35% | Cowen & Co. | Joshua Jennings | $28 → $14 | Maintains | Outperform | Get Alert |
| 02/22/2022 | PROF | Buy Now | Profound Medical | $8.03 | 186.43% | Raymond James | — | $28 → $23 | Downgrade | Strong Buy → Outperform | Get Alert |
FAQ
What is the target price for Profound Medical (PROF)?
The latest price target for Profound Medical (NASDAQ: PROF) was reported by Alliance Global Partners on March 11, 2024. The analyst firm set a price target for $10.80 expecting PROF to rise to within 12 months (a possible 34.50% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Profound Medical (PROF)?
The latest analyst rating for Profound Medical (NASDAQ: PROF) was provided by Alliance Global Partners, and Profound Medical maintained their buy rating.
When was the last upgrade for Profound Medical (PROF)?
The last upgrade for Profound Medical Corp happened on November 4, 2022 when Raymond James raised their price target to N/A. Raymond James previously had an outperform for Profound Medical Corp.
When was the last downgrade for Profound Medical (PROF)?
The last downgrade for Profound Medical Corp happened on August 4, 2023 when Raymond James changed their price target from N/A to N/A for Profound Medical Corp.
When is the next analyst rating going to be posted or updated for Profound Medical (PROF)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Profound Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Profound Medical was filed on March 11, 2024 so you should expect the next rating to be made available sometime around March 11, 2025.
Is the Analyst Rating Profound Medical (PROF) correct?
While ratings are subjective and will change, the latest Profound Medical (PROF) rating was a maintained with a price target of $12.75 to $10.80. The current price Profound Medical (PROF) is trading at is $8.03, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.